Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product
  • Research
    • Overview
    • Published Journal Articles
  • The Market
  • News
  • Contact Us

Pulmotect Awarded Up To $6M From Department of Defense to Complete Two COVID-19 Trials

Posted on January 27, 2021January 27, 2021 by Brenton Scott

Posted in Press Releases

Post navigation

Coronavirus protection drug approved by FDA for testing in Houston
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2021
Pulmotect, Inc.
Website by Geisler Young